1-9 of 9
Robert Radinsky
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Association of somatic kRAS gene mutations and clinical outcome from a phase 2 mCRC trial of panitumumab

Todd Juan, Dan Freeman, Ildiko Sarosi, Will Baron, Mike Wolf, Rafael Amado, Robert Radinsky
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (19_Supplement): B39.
Published: 15 August 2014
View article titled, Association of somatic kRAS gene mutations and clinical outcome from a phase 2 mCRC trial of panitumumab
Journal Articles

Broad Antitumor Activity in Breast Cancer Xenografts by Motesanib, a Highly Selective, Oral Inhibitor of Vascular Endothelial Growth Factor, Platelet-Derived Growth Factor, and Kit Receptors

Angela Coxon, Tammy Bush, Douglas Saffran, Stephen Kaufman, Brian Belmontes, Karen Rex, Paul Hughes, Sean Caenepeel, James B. Rottman, Andrew Tasker, Vinod Patel, Richard Kendall, Robert Radinsky, Anthony Polverino
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (1): 110–118.
https://doi.org/10.1158/1078-0432.CCR-08-1155
Published: 31 December 2008
View article titled, Broad Antitumor Activity in Breast Cancer Xenografts by Motesanib, a Highly Selective, Oral Inhibitor of Vascular Endothelial Growth Factor, Platelet-Derived Growth Factor, and Kit Receptors
Open the PDF for Broad Antitumor Activity in Breast Cancer Xenografts by Motesanib, a Highly Selective, Oral Inhibitor of Vascular Endothelial Growth Factor, Platelet-Derived Growth Factor, and Kit Receptors in another window
Journal Articles

AMG 102, A Fully Human Anti-Hepatocyte Growth Factor/Scatter Factor Neutralizing Antibody, Enhances the Efficacy of Temozolomide or Docetaxel in U-87 MG Cells and Xenografts

H. Toni Jun, Jan Sun, Karen Rex, Robert Radinsky, Richard Kendall, Angela Coxon, Teresa L. Burgess
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (22): 6735–6742.
https://doi.org/10.1158/1078-0432.CCR-06-2969
Published: 15 November 2007
View article titled, AMG 102, A Fully Human Anti-Hepatocyte Growth Factor/Scatter Factor Neutralizing Antibody, Enhances the Efficacy of Temozolomide or Docetaxel in U-87 MG Cells and Xenografts
Open the PDF for AMG 102, A Fully Human Anti-Hepatocyte Growth Factor/Scatter Factor Neutralizing Antibody, Enhances the Efficacy of Temozolomide or Docetaxel in U-87 MG Cells and Xenografts in another window
Journal Articles

Blockade of Insulin-like Growth Factor I Receptor Function Inhibits Growth and Angiogenesis of Colon Cancer

Niels Reinmuth, Wenbiao Liu, Fan Fan, Young D. Jung, Syed A. Ahmad, Oliver Stoeltzing, Corazon D. Bucana, Robert Radinsky, Lee M. Ellis
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (10): 3259–3269.
Published: 01 October 2002
View article titled, Blockade of Insulin-like Growth Factor I Receptor Function Inhibits Growth and Angiogenesis of Colon Cancer
Open the PDF for Blockade of Insulin-like Growth Factor I Receptor Function Inhibits Growth and Angiogenesis of Colon Cancer in another window
Journal Articles

Paclitaxel Enhances the Effects of the Anti-Epidermal Growth Factor Receptor Monoclonal Antibody ImClone C225 in Mice with Metastatic Human Bladder Transitional Cell Carcinoma

Keiji Inoue, Joel W. Slaton, Paul Perrotte, Darren W. Davis, Christiane J. Bruns, Daniel J. Hicklin, David J. McConkey, Paul Sweeney, Robert Radinsky, Colin P. N. Dinney
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (12): 4874–4884.
Published: 01 December 2000
View article titled, Paclitaxel Enhances the Effects of the Anti-Epidermal Growth Factor Receptor Monoclonal Antibody ImClone C225 in Mice with Metastatic Human Bladder Transitional Cell Carcinoma
Open the PDF for Paclitaxel Enhances the Effects of the Anti-Epidermal Growth Factor Receptor Monoclonal Antibody ImClone C225 in Mice with Metastatic Human Bladder Transitional Cell Carcinoma in another window
Journal Articles

Treatment of Human Metastatic Transitional Cell Carcinoma of the Bladder in a Murine Model with the Anti-Vascular Endothelial Growth Factor Receptor Monoclonal Antibody DC101 and Paclitaxel

Keiji Inoue, Joel W. Slaton, Darren W. Davis, Daniel J. Hicklin, David J. McConkey, Takashi Karashima, Robert Radinsky, Colin P. N. Dinney
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (7): 2635–2643.
Published: 01 July 2000
View article titled, Treatment of Human Metastatic Transitional Cell Carcinoma of the Bladder in a Murine Model with the Anti-Vascular Endothelial Growth Factor Receptor Monoclonal Antibody DC101 and Paclitaxel
Open the PDF for Treatment of Human Metastatic Transitional Cell Carcinoma of the Bladder in a Murine Model with the Anti-Vascular Endothelial Growth Factor Receptor Monoclonal Antibody DC101 and Paclitaxel in another window
Journal Articles

Epidermal Growth Factor Receptor Blockade with C225 Plus Gemcitabine Results in Regression of Human Pancreatic Carcinoma Growing Orthotopically in Nude Mice by Antiangiogenic Mechanisms

Christiane J. Bruns, Matthew T. Harbison, Darren W. Davis, Charles A. Portera, Rachel Tsan, David J. McConkey, Douglas B. Evans, James L. Abbruzzese, Daniel J. Hicklin, Robert Radinsky
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (5): 1936–1948.
Published: 01 May 2000
View article titled, Epidermal Growth Factor Receptor Blockade with C225 Plus Gemcitabine Results in Regression of Human Pancreatic Carcinoma Growing Orthotopically in Nude Mice by Antiangiogenic Mechanisms
Open the PDF for Epidermal Growth Factor Receptor Blockade with C225 Plus Gemcitabine Results in Regression of Human Pancreatic Carcinoma Growing Orthotopically in Nude Mice by Antiangiogenic Mechanisms in another window
Journal Articles

Interleukin 8 Expression Regulates Tumorigenicity and Metastases in Androgen-independent Prostate Cancer

Keiji Inoue, Joel W. Slaton, Beryl Y. Eve, Sun Jin Kim, Paul Perrotte, M. Derya Balbay, Seiji Yano, Menashe Bar-Eli, Robert Radinsky, Curtis A. Pettaway, Colin P. N. Dinney
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (5): 2104–2119.
Published: 01 May 2000
View article titled, Interleukin 8 Expression Regulates Tumorigenicity and Metastases in Androgen-independent Prostate Cancer
Open the PDF for Interleukin 8 Expression Regulates Tumorigenicity and Metastases in Androgen-independent Prostate Cancer in another window
Journal Articles

Anti-epidermal Growth Factor Receptor Antibody C225 Inhibits Angiogenesis in Human Transitional Cell Carcinoma Growing Orthotopically in Nude Mice

Paul Perrotte, Takashi Matsumoto, Keiji Inoue, Hiroki Kuniyasu, Beryl Y. Eve, Daniel J. Hicklin, Robert Radinsky, Colin P. N. Dinney
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (2): 257–264.
Published: 01 February 1999
View article titled, Anti-epidermal Growth Factor Receptor Antibody C225 Inhibits Angiogenesis in Human Transitional Cell Carcinoma Growing Orthotopically in Nude Mice
Open the PDF for Anti-epidermal Growth Factor Receptor Antibody C225 Inhibits Angiogenesis in Human Transitional Cell Carcinoma Growing Orthotopically in Nude Mice in another window